×

IPCI – intellipharmaceutics (US:NASDAQ)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day IPCI SPY QQQ SPX
Date
Time
Symbol
Headline
Impact
Date
Time
Symbol
Company Name
Action
%Chg
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny

Odd Lot

Avg. bid-ask spread

Avg. bid / ask size


Shares at ask / bid


Off exchange

Top News Decliners
7/26 FDA panel votes against 'abuse-deterrent' opioid with blue dye [ABC News] -45.6%
10/10 BRIEF-Intellipharmaceutics- Q3 loss per share $0.08 [Reuters] -22.9%
8/8 SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Encourages Investors with Losses to Contact the Firm -12.4%
8/15 IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm -11.9%
7/21 Intellipharmaceutics International Inc. (NASDAQ: IPCI) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $6.00 price target on the stock. -10.0%
8/7 INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Encourages Investors with Losses to Contact the Firm -9.5%
2/2 FDA to review Intellipharmaceutics' NDA for abuse-deterrent oxycodone; shares ahead 10% after hours [Seeking Alpha] -8.4%
8/11 The Klein Law Firm Notifies Investors of Class Actions Filed on Behalf of Intellipharmaceutics International Inc. Shareholders and a Lead Plaintiff Deadline of September 29, 2017 -8.0%
2/24 Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage® XR [Canadian Business Journal (Canada)] -7.9%
4/10 Intellipharmaceutics Announces Patent Litigation by Purdue against its Rexista™ Abuse-Deterrent Extended-Release Oxycodone -7.9%

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.